That's certainly the case for prostate cancer screening in men, according to researchers in Canada who last week recommended scrapping PSA (prostate-specific antigen) testing, even for those considered high risk.
It's astonishing to realise that in spite of our advanced medical technology and years of dedicated research, there are no biomarkers approved for the screening of breast or lung cancer - the two most cancers for men and women around the world.
When it comes to screening, it's not a bad idea to look before you leap. Don't fall for the old lead time bias, or the description of the test being initially 'simple' - ask how having screening affects the mortality rate, weigh up the pros and cons, and make up your own mind.
Every year, Human Rights Day spurs debate around the world about what constitutes a human right. Much-vaunted, often controversial, and little understood, it seems there's still a great deal of contention about which rights are most important.